Merck (MRK) Change in Cash (2009 - 2026)

Merck (MRK) reported Change in Cash of -$9.3 billion for Q1 2026, down 102.62% year-over-year from $355.1 billion in Q1 2025, and down 160.28% quarter-over-quarter from -$3.6 billion in Q4 2025.

Merck (MRK) Change in Cash (2009 - 2026) Analysis & Trends

Merck (MRK) has 18 years of Change in Cash data on file, last reported at -$9.3 billion in Q1 2026.

  • Change in Cash for Q1 2026 came in at -$9.3 billion, down 102.62% year-over-year; the trailing twelve-month figure through Mar 2026 was -$3.3 billion (down 208.92% YoY), and the FY2025 annual result was $1.4 billion, down 78.59% from the prior year.
  • Change in Cash slipped to -$9.3 billion in Q1 2026 per MRK's latest filing, from -$3.6 billion in the prior quarter.
  • Over five years, Change in Cash peaked at $10.2 billion in Q3 2025 and troughed at -$9.3 billion in Q1 2026.
  • A 5-year average of -$162.9 million and a median of -$659.0 million in 2025 frame the typical range for Change in Cash.
  • The sharpest annual moves came in 2023 and 2024: Change in Cash sank 768.23% in 2023, then surged 239.96% in 2024.
  • A 5-year view of Change in Cash shows it stood at $1.5 billion in 2022, then sank by 217.8% to -$1.8 billion in 2023, then increased by 22.16% to -$1.4 billion in 2024, then sank by 160.58% to -$3.6 billion in 2025, then sank by 160.28% to -$9.3 billion in 2026.
  • Business Quant data shows MRK's Change in Cash at -$9.3 billion in Q1 2026, -$3.6 billion in Q4 2025, and $10.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -71.45 Mn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn -1.99 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 1.98 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 4.16 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn -9.29 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 2.91 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 65.00 Mn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 563.00 Mn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn -635.00 Mn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.29 Bn
Dec 31, 2025 -3.57 Bn
Sep 30, 2025 10.19 Bn
Jun 30, 2025 -659.00 Mn
Mar 31, 2025 -4.59 Bn
Dec 31, 2024 -1.37 Bn
Sep 30, 2024 3.32 Bn
Jun 30, 2024 5.70 Bn
Mar 31, 2024 -1.24 Bn
Dec 31, 2023 -1.76 Bn
Sep 30, 2023 2.96 Bn
Jun 30, 2023 -4.07 Bn
Mar 31, 2023 -2.99 Bn
Dec 31, 2022 1.49 Bn
Sep 30, 2022 1.53 Bn
Jun 30, 2022 1.14 Bn
Mar 31, 2022 447.00 Mn
Dec 31, 2021 -1.88 Bn
Sep 30, 2021 1.42 Bn
Jun 30, 2021 1.62 Bn